Effects of Mother-infant Skin-to-skin Contact in Postpartum Women

August 13, 2025 updated by: Ming-Chih Chang, Jen-Ai Hospital Institutional Review Board

Department of Nurse-Midwifery and Women Health Graduate Institute of Nurse-Nurse-Midwifery

When a newborn is delivered in good physiological condition, immediate skin-to-skin contact with the mother is required. Skin-to-skin contact has a wide range of benefits for both mother and baby. The implementation time can start from the birth of the newborn and continue until thereafter. There are benefits both in the short and long term, such as physiological stability, parent-child relationship development, and stability of children's behavioral development. There were 108 cases admitted and the attrition rate was 10%. Therefore, the total number of cases admitted was 118, divided into experimental groups and control groups, and intervention measures were implemented in the experimental group. From the 1st to the 30th day after delivery, there is 1 hour of skin-to-skin contact between mother and baby every day. Fill out the Sleep Quality Visual Analog Scale, Maternal Confidence Scale, and Mother-Infant Bonding Scale on the day after delivery and at one month later.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

According to the World Health Organization's clinical care guidelines for childbirth, neonatal care in the third stage of labor: When the newborn is delivered in good physiological condition, it needs to have skin-to-skin contact with the mother immediately. Skin-to-skin contact has extensive benefits for both mother and baby. The implementation time can start from the birth of the newborn and continue thereafter. It has benefits in both the short and long term, such as physiological stability, parent-child relationship development, and child behavioral development stability, etc. Therefore, this study was designed as a quasi-experimental study, using a random method to accept cases. The number of admitted cases was 128, and the attrition rate was 10%. Therefore, the total number of admitted cases was 140, divided into experimental groups and control groups, with intervention measures for the experimental group, and intervention measures. From the 1st to 30th day after delivery, there was 1 hour of skin-to-skin contact between mother and baby every day. On the postpartum day and at the full moon, the sleep quality visual analog scale, maternal confidence scale, and mother-infant bonding scale were filled in, and the statistical method was chi-square. Test, independent sample t test, sample t test, Pearson correlation test, simple regression analysis of the relationship between independent variables and dependent variables and the difference between the experimental group and the control group.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Taichung, Taiwan, 412224
        • Jung Ti

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Vaginal delivery to primiparous women
  2. Full-term delivery over 37 weeks
  3. The pregnancy and delivery process are low-risk cases
  4. Can listen, listen, read and write Chinese
  5. Agree to participate in this study
  6. No mental condition
  7. The newborn's vital signs are stable after birth
  8. The body appearance is normal after birth and there are no other complications.
  9. Can be discharged from hospital together with mother

Exclusion Criteria:

(1)Transfer of newborn to sick nursery after birth

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: usual care
Experimental: SKIN TO SKIN
Daily skin-to skin contact within 30 days of postpartum
Other: skin to skin
Intervention measures include 1 hour of skin-to-skin contact between mother and baby every day from day 1 to day 30 postpartum.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sleep quity Visual Analogue Scale
Time Frame: postpartum 30 DAY
A score of 0 is the worst sleep quality A score Score 10 points for best sleep quality
postpartum 30 DAY
maternal confidence scale
Time Frame: postpartum 30 DAY
A score of 0 means never A score of 1 means very little A score of 2 means sometimes A score of 3 mean often A score of 4 mean always The higher the score, the higher the confidence in parenting.
postpartum 30 DAY
bonding scale
Time Frame: postpartum 30 DAY
A score of 1 represents strongly disagree, A score of 2 means disagreement, A score of 3 means somewhat disagreeing, A score of 4 means somewhat agree, A score of 5 means agreement A score of 6 means strongly agree The higher the score, the closer the emotional connection between mother and baby.
postpartum 30 DAY

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Jen-Ai Hospital Institutional Review Board

Investigators

  • Study Director: TSAN-WEN HUANG, college, Jen-Ai Hospital Institutional Review Board

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 24, 2023

Primary Completion (Actual)

May 31, 2025

Study Completion (Actual)

May 31, 2025

Study Registration Dates

First Submitted

April 6, 2024

First Submitted That Met QC Criteria

January 15, 2025

First Posted (Actual)

January 17, 2025

Study Record Updates

Last Update Posted (Actual)

August 14, 2025

Last Update Submitted That Met QC Criteria

August 13, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • JenAiH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Attachment

Clinical Trials on skin to skin

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe